BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31377316)

  • 21. Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development.
    Tedeschi PM; Vazquez A; Kerrigan JE; Bertino JR
    Mol Cancer Res; 2015 Oct; 13(10):1361-6. PubMed ID: 26101208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deacetylation of MTHFD2 by SIRT4 senses stress signal to inhibit cancer cell growth by remodeling folate metabolism.
    Zhang F; Wang D; Li J; Su Y; Liu S; Lei QY; Yin M
    J Mol Cell Biol; 2022 Jul; 14(4):. PubMed ID: 35349697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural product carolacton inhibits folate-dependent C1 metabolism by targeting FolD/MTHFD.
    Fu C; Sikandar A; Donner J; Zaburannyi N; Herrmann J; Reck M; Wagner-Döbler I; Koehnke J; Müller R
    Nat Commun; 2017 Nov; 8(1):1529. PubMed ID: 29142318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC.
    Geng QQ; Wu QF; Zhang Y; Zhang GJ; Fu JK; Chen NZ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9473-9479. PubMed ID: 33015789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer.
    Achreja A; Yu T; Mittal A; Choppara S; Animasahun O; Nenwani M; Wuchu F; Meurs N; Mohan A; Jeon JH; Sarangi I; Jayaraman A; Owen S; Kulkarni R; Cusato M; Weinberg F; Kweon HK; Subramanian C; Wicha MS; Merajver SD; Nagrath S; Cho KR; DiFeo A; Lu X; Nagrath D
    Nat Metab; 2022 Sep; 4(9):1119-1137. PubMed ID: 36131208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
    Shang M; Yang H; Yang R; Chen T; Fu Y; Li Y; Fang X; Zhang K; Zhang J; Li H; Cao X; Gu J; Xiao J; Zhang Q; Liu X; Yu Q; Wang T
    Nat Commun; 2021 Mar; 12(1):1940. PubMed ID: 33782411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy.
    Yang C; Zhang J; Liao M; Yang Y; Wang Y; Yuan Y; Ouyang L
    Drug Discov Today; 2021 Mar; 26(3):817-825. PubMed ID: 33316375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion.
    Koufaris C; Gallage S; Yang T; Lau CH; Valbuena GN; Keun HC
    J Proteome Res; 2016 Aug; 15(8):2618-25. PubMed ID: 27315223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells.
    Hitzel J; Lee E; Zhang Y; Bibli SI; Li X; Zukunft S; Pflüger B; Hu J; Schürmann C; Vasconez AE; Oo JA; Kratzer A; Kumar S; Rezende F; Josipovic I; Thomas D; Giral H; Schreiber Y; Geisslinger G; Fork C; Yang X; Sigala F; Romanoski CE; Kroll J; Jo H; Landmesser U; Lusis AJ; Namgaladze D; Fleming I; Leisegang MS; Zhu J; Brandes RP
    Nat Commun; 2018 Jun; 9(1):2292. PubMed ID: 29895827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Expression of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Esophageal Squamous Cell Carcinoma and its Clinical Prognostic Significance.
    He H; Li PC; Jia W; Hu B; Ji CS
    Med Sci Monit; 2020 Feb; 26():e920259. PubMed ID: 32088725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammalian MTHFD2L encodes a mitochondrial methylenetetrahydrofolate dehydrogenase isozyme expressed in adult tissues.
    Bolusani S; Young BA; Cole NA; Tibbetts AS; Momb J; Bryant JD; Solmonson A; Appling DR
    J Biol Chem; 2011 Feb; 286(7):5166-74. PubMed ID: 21163947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression.
    Mo X; Liu Q; Liang K; Song Y
    J Bioenerg Biomembr; 2024 Jun; 56(3):333-345. PubMed ID: 38488992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.
    Wang LW; Shen H; Nobre L; Ersing I; Paulo JA; Trudeau S; Wang Z; Smith NA; Ma Y; Reinstadler B; Nomburg J; Sommermann T; Cahir-McFarland E; Gygi SP; Mootha VK; Weekes MP; Gewurz BE
    Cell Metab; 2019 Sep; 30(3):539-555.e11. PubMed ID: 31257153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate enzyme MTHFD2 links one-carbon metabolism to unfolded protein response in glioblastoma.
    Zhu Z; Kiang KM; Li N; Liu J; Zhang P; Jin L; He X; Zhang S; Leung GK
    Cancer Lett; 2022 Nov; 549():215903. PubMed ID: 36089117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MTHFD2, metabolic mastermind of CD4
    Gouirand V; Rosenblum MD
    Sci Immunol; 2022 Mar; 7(69):eabo6765. PubMed ID: 35245088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel oral inhibitor for one-carbon metabolism and checkpoint kinase 1 inhibitor as a rational combination treatment for breast cancer.
    Lee J; Chen X; Wang Y; Nishimura T; Li M; Ishikawa S; Daikoku T; Kawai J; Tojo A; Gotoh N
    Biochem Biophys Res Commun; 2021 Dec; 584():7-14. PubMed ID: 34753066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.
    Lehtinen L; Ketola K; Mäkelä R; Mpindi JP; Viitala M; Kallioniemi O; Iljin K
    Oncotarget; 2013 Jan; 4(1):48-63. PubMed ID: 23295955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newcastle Disease Virus Manipulates Mitochondrial MTHFD2-Mediated Nucleotide Metabolism for Virus Replication.
    Tang N; Chen P; Zhao C; Liu P; Tan L; Song C; Qiu X; Liao Y; Liu X; Luo T; Sun Y; Ding C
    J Virol; 2023 Mar; 97(3):e0001623. PubMed ID: 36794935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress.
    Bonagas N; Gustafsson NMS; Henriksson M; Marttila P; Gustafsson R; Wiita E; Borhade S; Green AC; Vallin KSA; Sarno A; Svensson R; Göktürk C; Pham T; Jemth AS; Loseva O; Cookson V; Kiweler N; Sandberg L; Rasti A; Unterlass JE; Haraldsson M; Andersson Y; Scaletti ER; Bengtsson C; Paulin CBJ; Sanjiv K; Abdurakhmanov E; Pudelko L; Kunz B; Desroses M; Iliev P; Färnegårdh K; Krämer A; Garg N; Michel M; Häggblad S; Jarvius M; Kalderén C; Jensen AB; Almlöf I; Karsten S; Zhang SM; Häggblad M; Eriksson A; Liu J; Glinghammar B; Nekhotiaeva N; Klingegård F; Koolmeister T; Martens U; Llona-Minguez S; Moulson R; Nordström H; Parrow V; Dahllund L; Sjöberg B; Vargas IL; Vo DD; Wannberg J; Knapp S; Krokan HE; Arvidsson PI; Scobie M; Meiser J; Stenmark P; Berglund UW; Homan EJ; Helleday T
    Nat Cancer; 2022 Feb; 3(2):156-172. PubMed ID: 35228749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation.
    Gustafsson Sheppard N; Jarl L; Mahadessian D; Strittmatter L; Schmidt A; Madhusudan N; Tegnér J; Lundberg EK; Asplund A; Jain M; Nilsson R
    Sci Rep; 2015 Oct; 5():15029. PubMed ID: 26461067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.